Biotechnology Stocks
231 US-listed companies in the Biotechnology industry, part of the Healthcare sector, ranked by market capitalisation. Open any ticker for quotes, charts, financials and analyst ratings.
Companies
231
Market cap
1.22T
P/E
19.4
Div yield
0.15%
Perf 1M
-0.61%
Perf YTD
39.40%
All 231 Biotechnology stocks
| Ticker | Company | Price | Change | Market cap | P/E | Perf YTD |
|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 530.88 | 1.89% | 130.85B | 30.1 | 14.93% |
| MRNA | Moderna, Inc. | 216.57 | 4.14% | 83.51B | — | 605.22% |
| REGN | Regeneron Pharmaceuticals, Inc. | 819.61 | 0.43% | 83.09B | 20.0 | 5.73% |
| ARGX | argenx SE | 894.74 | 1.39% | 55.11B | 40.9 | 4.94% |
| RVMD | Revolution Medicines, Inc. | 188.44 | 1.19% | 39.74B | — | 133.80% |
| ONC | BeOne Medicines AG | 375.40 | 2.55% | 38.98B | 5.0 | 20.49% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 225.19 | -0.71% | 29.72B | 37.5 | -42.97% |
| GMAB | Genmab A/S | 58.20 | 30.29% | 27.74B | 35.5 | 45.03% |
| ROIV | Roivant Sciences Ltd. | 36.89 | 0.96% | 26.24B | — | 68.39% |
| UTHR | United Therapeutics Corporation | 587.13 | -0.69% | 25.10B | 21.0 | 21.33% |
| INCY | Incyte Corporation | 118.18 | 1.36% | 23.57B | 14.8 | 18.05% |
| BNTX | BioNTech SE | 87.67 | 0.70% | 21.80B | — | -8.55% |
| INSM | Insmed Incorporated | 96.39 | 1.51% | 20.64B | — | -45.44% |
| EXEL | Exelixis, Inc. | 66.19 | 1.29% | 16.41B | 20.5 | 49.10% |
| ASND | Ascendis Pharma A/S | 247.69 | 0.75% | 15.30B | 18.3 | 15.29% |
| NBIX | Neurocrine Biosciences, Inc. | 145.45 | -0.38% | 14.73B | 21.2 | 2.94% |
| HALO | Halozyme Therapeutics, Inc. | 129.39 | 0.69% | 14.52B | 38.2 | 90.94% |
| BBIO | BridgeBio Pharma, Inc. | 69.90 | 0.76% | 13.48B | — | -9.31% |
| JAZZ | Jazz Pharmaceuticals plc | 205.39 | -0.67% | 13.39B | 14.1 | 21.64% |
| SMMT | Summit Therapeutics Inc. | 15.46 | 0.82% | 12.08B | — | -12.35% |
| TECH | Bio-Techne Corporation | 72.70 | 0.14% | 11.39B | 62.6 | 23.45% |
| TWST | Twist Bioscience Corporation | 177.90 | 11.29% | 11.08B | — | 403.94% |
| BMRN | BioMarin Pharmaceutical Inc. | 56.01 | 1.20% | 10.77B | 142.7 | -6.87% |
| TXG | 10x Genomics, Inc. | 86.56 | 10.95% | 10.63B | — | 378.36% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 434.96 | -1.22% | 10.09B | — | -24.39% |
| CAI | Caris Life Sciences, Inc. | 35.96 | 6.80% | 9.68B | 95.1 | 24.80% |
| KYMR | Kymera Therapeutics, Inc. | 121.32 | 3.19% | 9.62B | — | 51.10% |
| KRYS | Krystal Biotech, Inc. | 320.20 | -0.12% | 9.45B | 40.0 | 30.03% |
| PCVX | Vaxcyte, Inc. | 60.64 | -0.05% | 9.45B | — | 31.49% |
| SYRE | Spyre Therapeutics, Inc. | 99.67 | 0.63% | 9.16B | — | 202.35% |
| PTGX | Protagonist Therapeutics, Inc. | 143.10 | 1.41% | 9.14B | 137.1 | 61.58% |
| IBRX | ImmunityBio, Inc. | 8.72 | 1.10% | 9.10B | — | 335.86% |
| TGTX | TG Therapeutics, Inc. | 56.20 | -0.42% | 8.59B | 20.5 | 89.33% |
| CYTK | Cytokinetics, Incorporated | 60.86 | -1.08% | 8.42B | — | -3.18% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 59.35 | 0.54% | 8.28B | — | -11.09% |
| PRAX | Praxis Precision Medicines, Inc. | 282.00 | 5.38% | 7.71B | — | -9.21% |
| ABVX | Abivax S.A. | 89.38 | 2.74% | 7.65B | — | -35.48% |
| AXSM | Axsome Therapeutics, Inc. | 143.56 | 0.96% | 7.39B | — | -22.14% |
| IONS | Ionis Pharmaceuticals, Inc. | 43.90 | -0.15% | 7.19B | — | -44.43% |
| IOVA | Iovance Biotherapeutics, Inc. | 14.86 | 1.92% | 6.60B | — | 434.07% |
| ORKA | Oruka Therapeutics, Inc. | 97.00 | 1.24% | 6.35B | — | 216.10% |
| RYTM | Rhythm Pharmaceuticals, Inc. | 91.97 | -0.23% | 6.29B | — | -13.88% |
| LGND | Ligand Pharmaceuticals Incorporated | 313.06 | 0.43% | 6.21B | 33.3 | 64.88% |
| IMVT | Immunovant, Inc. | 29.06 | 0.62% | 5.91B | — | 13.61% |
| KOD | Kodiak Sciences Inc. | 96.76 | 5.96% | 5.84B | — | 226.61% |
| BLTE | Belite Bio, Inc | 146.81 | 0.75% | 5.82B | — | -8.90% |
| MANE | Veradermics, Incorporated | 140.12 | -0.43% | 5.79B | — | 313.88% |
| CGON | CG Oncology Inc. | 64.00 | 1.68% | 5.58B | — | 51.59% |
| MIRM | Mirum Pharmaceuticals, Inc. | 86.56 | 1.17% | 5.57B | — | 8.32% |
| COGT | Cogent Biosciences, Inc. | 32.50 | 1.53% | 5.52B | — | -9.88% |
| SRRK | Scholar Rock Holding Corporation | 43.51 | 2.40% | 5.27B | — | -3.54% |
| ERAS | Erasca, Inc. | 15.28 | 0.39% | 5.26B | — | 309.14% |
| PTCT | PTC Therapeutics, Inc. | 62.26 | 0.27% | 5.14B | — | -18.26% |
| DFTX | Definium Therapeutics, Inc. | 38.20 | 3.02% | 4.98B | — | 176.92% |
| CRSP | CRISPR Therapeutics AG | 52.65 | 2.28% | 4.97B | — | -1.85% |
| TVTX | Travere Therapeutics, Inc. | 50.35 | -1.04% | 4.72B | — | 33.16% |
| ADPT | Adaptive Biotechnologies Corporation | 28.66 | 3.61% | 4.51B | — | 70.32% |
| DNTH | Dianthus Therapeutics, Inc. | 79.11 | -0.52% | 4.39B | — | 92.96% |
| ABCL | AbCellera Biologics Inc. | 13.42 | 4.60% | 4.26B | — | 275.15% |
| EWTX | Edgewise Therapeutics, Inc. | 40.42 | 2.24% | 4.21B | — | 59.27% |
| RLAY | Relay Therapeutics, Inc. | 19.49 | 3.44% | 4.12B | — | 122.70% |
| ARQT | Arcutis Biotherapeutics, Inc. | 31.82 | 0.46% | 3.98B | 150.6 | 9.09% |
| LEGN | Legend Biotech Corporation | 22.79 | 5.71% | 3.93B | — | -0.83% |
| TNGX | Tango Therapeutics, Inc. | 23.62 | 3.19% | 3.84B | — | 158.35% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 28.16 | -0.51% | 3.47B | — | 134.27% |
| XENE | Xenon Pharmaceuticals Inc. | 36.41 | 1.11% | 3.46B | — | -19.66% |
| ACAD | Acadia Pharmaceuticals Inc. | 20.25 | 0.40% | 3.45B | 9.0 | -24.49% |
| CELC | Celcuity Inc. | 68.90 | 1.22% | 3.32B | — | -31.75% |
| TARS | Tarsus Pharmaceuticals, Inc. | 71.91 | 1.63% | 3.27B | — | -13.58% |
| ELVN | Enliven Therapeutics, Inc. | 44.83 | 2.61% | 3.24B | — | 183.70% |
| IDYA | IDEAYA Biosciences, Inc. | 34.14 | 1.91% | 3.19B | — | -3.10% |
| TLX | Telix Pharmaceuticals Limited | 9.27 | 2.60% | 3.12B | 91.8 | 20.56% |
| VKTX | Viking Therapeutics, Inc. | 25.04 | 0.60% | 3.12B | — | -29.25% |
| DYN | Dyne Therapeutics, Inc. | 16.94 | 0.00% | 3.08B | — | -13.39% |
| IRON | Disc Medicine, Inc. | 81.91 | 2.52% | 3.06B | — | 0.62% |
| DNLI | Denali Therapeutics Inc. | 19.09 | -0.70% | 3.04B | — | 16.41% |
| NRIX | Nurix Therapeutics, Inc. | 26.92 | 0.82% | 2.90B | 11.5 | 40.75% |
| VRDN | Viridian Therapeutics, Inc. | 23.97 | -0.48% | 2.70B | — | -22.59% |
| BEAM | Beam Therapeutics Inc. | 27.29 | 9.58% | 2.61B | — | -10.17% |
| ZLAB | Zai Lab Limited | 23.44 | -0.59% | 2.60B | — | 33.67% |
| MBX | MBX Biosciences, Inc. Common Stock | 54.40 | 2.71% | 2.57B | — | 67.95% |
| ADMA | ADMA Biologics, Inc. | 11.20 | 0.27% | 2.49B | 15.9 | -38.76% |
| FTRE | Fortrea Holdings Inc. | 25.86 | 5.85% | 2.39B | — | 41.62% |
| NAMS | NewAmsterdam Pharma Company N.V. | 20.71 | 1.02% | 2.36B | — | -41.56% |
| CLDX | Celldex Therapeutics, Inc. | 29.66 | -1.62% | 2.33B | — | 11.01% |
| BHVN | Biohaven Ltd. | 15.69 | 2.62% | 2.30B | — | 35.43% |
| AUPH | Aurinia Pharmaceuticals Inc. | 17.27 | 0.12% | 2.28B | 7.5 | 8.15% |
| SLS | SELLAS Life Sciences Group, Inc. | 10.02 | -17.71% | 2.27B | — | 222.81% |
| RCUS | Arcus Biosciences, Inc. | 18.16 | 0.11% | 2.25B | — | -23.88% |
| RXRX | Recursion Pharmaceuticals, Inc. | 4.43 | 9.38% | 2.23B | — | -0.98% |
| PHVS | Pharvaris N.V. | 32.18 | 0.72% | 2.23B | — | 15.14% |
| AGIO | Agios Pharmaceuticals, Inc. | 38.10 | 0.18% | 2.22B | — | 39.71% |
| VCEL | Vericel Corporation | 42.82 | -1.04% | 2.21B | 91.7 | 20.16% |
| XNCR | Xencor, Inc. | 30.51 | 1.73% | 2.20B | — | 95.89% |
| HRMY | Harmony Biosciences Holdings, Inc. | 38.04 | 0.24% | 2.20B | 12.3 | 1.42% |
| IMNM | Immunome, Inc. | 18.88 | 0.58% | 2.20B | — | -12.62% |
| VERA | Vera Therapeutics, Inc. | 30.75 | 2.55% | 2.19B | — | -40.78% |
| PGEN | Precigen, Inc. | 6.29 | 2.20% | 2.18B | — | 47.13% |
| BCRX | BioCryst Pharmaceuticals, Inc. | 8.43 | 4.07% | 2.09B | — | 3.85% |
| LKFT | Lakefront Biotherapeutics N.V. | 32.27 | 1.43% | 2.08B | 3.0 | -2.69% |
| ZYME | Zymeworks Inc. | 29.20 | 1.20% | 2.08B | — | 9.57% |
| SEPN | Septerna Inc | 44.95 | 1.82% | 2.07B | — | 58.32% |
| SRPT | Sarepta Therapeutics, Inc. | 19.01 | 0.64% | 1.98B | — | -12.22% |
| VIR | Vir Biotechnology, Inc. | 11.80 | 1.99% | 1.95B | — | 91.87% |
| PVLA | Palvella Therapeutics, Inc. | 142.72 | 7.38% | 1.93B | — | 26.98% |
| XERS | Xeris Biopharma Holdings, Inc. | 10.73 | 2.73% | 1.91B | — | 33.12% |
| TRVI | Trevi Therapeutics, Inc. | 13.40 | 0.37% | 1.89B | — | 6.63% |
| ABSI | Absci Corporation | 11.55 | 9.32% | 1.87B | — | 202.87% |
| GENB | Generate Biomedicines, Inc. | 14.74 | 11.61% | 1.86B | — | -11.93% |
| MLYS | Mineralys Therapeutics, Inc. | 21.45 | 1.50% | 1.85B | — | -41.77% |
| ZBIO | Zenas BioPharma, Inc. | 28.63 | 4.85% | 1.78B | — | -24.81% |
| MAZE | Maze Therapeutics, Inc. | 31.71 | 0.08% | 1.77B | — | -23.51% |
| NTLA | Intellia Therapeutics, Inc. | 12.98 | 5.72% | 1.72B | — | 36.60% |
| MESO | Mesoblast Limited | 13.33 | 1.14% | 1.71B | — | -26.94% |
| KLRA | Kailera Therapeutics, Inc. | 13.13 | -0.04% | 1.70B | — | -49.50% |
| STOK | Stoke Therapeutics, Inc. | 26.38 | 0.96% | 1.67B | — | -17.67% |
| QURE | uniQure N.V. | 25.03 | 3.09% | 1.66B | — | 1.46% |
| RARE | Ultragenyx Pharmaceutical Inc. | 17.18 | 2.56% | 1.65B | — | -27.17% |
| URGN | UroGen Pharma Ltd. | 33.79 | -0.35% | 1.64B | — | 44.79% |
| NVAX | Novavax, Inc. | 10.26 | 2.35% | 1.64B | — | 49.11% |
| CMPS | COMPASS Pathways plc | 12.07 | 2.20% | 1.64B | — | 71.16% |
| IMCR | Immunocore Holdings plc | 32.12 | 0.51% | 1.62B | — | -7.92% |
| TRAX | First Tracks Biotherapeutics Inc | 45.40 | 0.04% | 1.61B | — | 121.26% |
| NBTX | Nanobiotix S.A. | 34.62 | 0.26% | 1.58B | — | 49.35% |
| NUVB | Nuvation Bio Inc. | 4.54 | -0.33% | 1.57B | — | -49.22% |
| INVA | Innoviva, Inc. | 21.06 | 0.57% | 1.51B | 5.1 | 4.75% |
| ANAB | AnaptysBio, Inc. | 50.07 | 0.88% | 1.49B | 9.3 | 53.56% |
| OCUL | Ocular Therapeutix, Inc. | 7.21 | 7.22% | 1.48B | — | -44.65% |
| INBX | Inhibrx Biosciences Inc. | 79.09 | -17.32% | 1.41B | — | 21.09% |
| TSHA | Taysha Gene Therapies, Inc. | 4.26 | 0.27% | 1.38B | — | -22.73% |
| GHRS | GH Research PLC | 20.47 | 2.25% | 1.38B | — | 57.64% |
| DMRA | Damora Therapeutics, Inc. | 22.16 | 0.92% | 1.35B | — | -4.56% |
| TYRA | Tyra Biosciences, Inc. | 21.55 | 0.13% | 1.27B | — | -18.14% |
| LBRX | LB Pharmaceuticals Inc Common Stock | 40.03 | 0.98% | 1.26B | — | 78.08% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 8.37 | 1.31% | 1.25B | — | 154.15% |
| OMER | Omeros Corporation | 17.56 | 0.39% | 1.25B | 10.1 | 1.80% |
| DRTS | Alpha Tau Medical Ltd | 13.58 | 0.49% | 1.25B | — | 172.93% |
| GPCR | Structure Therapeutics Inc. | 21.14 | -1.93% | 1.23B | — | -69.02% |
| SNDX | Syndax Pharmaceuticals, Inc. | 13.77 | 0.58% | 1.21B | — | -34.84% |
| REPL | Replimune Group, Inc. | 14.31 | 9.66% | 1.19B | — | 34.26% |
| BCAX | Bicara Therapeutics Inc. Common Stock | 10.27 | -41.25% | 1.15B | — | 3.86% |
| AVLN | Avalyn Pharma Inc. Common Stock | 25.58 | -0.98% | 1.14B | — | -0.65% |
| RAPP | Rapport Therapeutics, Inc. Common Stock | 22.86 | -16.99% | 1.14B | — | -9.23% |
| SPTX | Seaport Therapeutics, Inc. Common Stock | 20.70 | -2.73% | 1.10B | — | 1.33% |
| IMTX | Immatics N.V. | 7.37 | 1.52% | 1.09B | — | -30.86% |
| NKTR | Nektar Therapeutics | 38.20 | 0.61% | 1.08B | — | -10.19% |
| MNKD | MannKind Corporation | 3.35 | 1.98% | 1.05B | — | -41.98% |
| JANX | Janux Therapeutics, Inc. | 17.44 | 1.03% | 1.05B | — | 25.07% |
| SGP | SpyGlass Pharma, Inc. Common Stock | 30.99 | 0.29% | 1.03B | — | 28.75% |
| MLTX | MoonLake Immunotherapeutics | 12.31 | 3.16% | 1.00B | — | -9.48% |
| SVRA | Savara Inc. | 4.95 | 1.75% | 985.18M | — | -19.40% |
| RIGL | Rigel Pharmaceuticals, Inc. | 50.38 | -0.34% | 939.78M | 3.1 | 18.02% |
| SLN | Silence Therapeutics plc | 19.75 | -0.16% | 932.87M | — | 225.33% |
| ODTX | Odyssey Therapeutics, Inc. | 19.65 | 0.79% | 921.76M | — | -2.50% |
| CGEM | Cullinan Therapeutics, Inc. | 15.44 | 4.04% | 914.19M | — | 43.38% |
| ORIC | ORIC Pharmaceuticals, Inc. | 9.23 | 2.57% | 913.70M | — | 10.02% |
| JBIO | Jade Biosciences, Inc. | 14.68 | -0.41% | 910.62M | — | -4.47% |
| GLUE | Monte Rosa Therapeutics, Inc. | 10.57 | -0.88% | 906.03M | — | -32.02% |
| MGTX | MeiraGTx Holdings plc | 9.46 | 0.61% | 903.76M | 13.3 | 18.24% |
| ANRO | Alto Neuroscience, Inc. | 23.24 | 0.22% | 879.81M | — | 30.28% |
| AKTS | Aktis Oncology, Inc. | 16.84 | 2.40% | 876.34M | — | -39.07% |
| KURA | Kura Oncology, Inc. | 10.39 | 4.95% | 876.26M | — | -4.72% |
| CRVS | Corvus Pharmaceuticals, Inc. | 10.59 | 0.52% | 870.58M | — | 36.88% |
| ALMS | Alumis Inc. | 6.81 | 2.56% | 859.45M | — | -31.97% |
| ABUS | Arbutus Biopharma Corp | 4.30 | 0.13% | 842.94M | 5.5 | -10.81% |
| DNA | Ginkgo Bioworks Holdings, Inc. | 13.11 | 16.33% | 804.04M | — | 35.62% |
| PRME | Prime Medicine, Inc. | 5.07 | 16.44% | 794.74M | — | 25.36% |
| AVBP | ArriVent BioPharma, Inc. | 15.79 | 2.56% | 765.75M | — | -23.46% |
| PHAR | Pharming Group N.V. | 12.15 | 2.36% | 751.06M | 91.2 | -32.82% |
| ARDX | Ardelyx, Inc. | 3.00 | 0.17% | 738.84M | — | -48.54% |
| SANA | Sana Biotechnology, Inc. | 2.48 | 0.20% | 734.93M | — | -39.31% |
| ACHV | Achieve Life Sciences, Inc. | 6.93 | -0.14% | 715.68M | — | 39.44% |
| GYRE | Gyre Therapeutics, Inc. | 6.88 | 5.36% | 688.69M | — | -7.51% |
| WVE | Wave Life Sciences Ltd. | 3.50 | 1.59% | 673.71M | — | -79.71% |
| IMMX | Immix Biopharma, Inc. | 8.16 | 1.37% | 665.71M | — | 53.92% |
| FDMT | 4D Molecular Therapeutics, Inc. | 12.14 | 1.50% | 661.27M | — | 59.47% |
| SLDB | Solid Biosciences Inc. | 6.34 | 2.42% | 658.36M | — | 9.75% |
| DSGN | Design Therapeutics, Inc. | 10.99 | 3.39% | 656.17M | — | 13.33% |
| LXRX | Lexicon Pharmaceuticals, Inc. | 1.45 | -2.36% | 649.64M | — | 28.70% |
| AURA | Aura Biosciences, Inc. | 6.29 | -0.08% | 646.55M | — | 15.60% |
| CADL | Candel Therapeutics, Inc. | 8.48 | 2.85% | 635.82M | — | 46.02% |
| CRMD | CorMedix Inc. | 7.93 | -0.88% | 621.22M | 3.7 | -31.21% |
| ANNX | Annexon, Inc. | 4.00 | 6.33% | 620.14M | — | -25.10% |
| OLMA | Olema Pharmaceuticals, Inc. | 7.14 | 1.39% | 601.11M | — | -71.84% |
| ZVRA | Zevra Therapeutics, Inc. | 10.24 | 1.88% | 592.65M | 10.7 | 12.28% |
| ANL | Adlai Nortye Ltd. | 10.58 | -1.21% | 569.02M | — | 654.23% |
| MDXG | MiMedx Group, Inc. | 3.94 | 0.90% | 567.01M | 97.3 | -42.39% |
| GERN | Geron Corporation | 0.89 | -22.46% | 565.44M | — | -12.88% |
| PBYI | Puma Biotechnology, Inc. | 10.81 | -1.03% | 558.53M | 20.8 | 83.53% |
| ACRS | Aclaris Therapeutics, Inc. | 3.77 | -0.66% | 557.88M | — | 25.91% |
| CLYM | Climb Bio, Inc. | 9.79 | 2.25% | 540.48M | — | 139.25% |
| VALN | Valneva SE | 5.73 | 2.87% | 530.06M | — | -36.85% |
| DRUG | Bright Minds Biosciences Inc. | 54.50 | 0.89% | 529.01M | — | -30.78% |
| CTMX | CytomX Therapeutics, Inc. | 2.38 | 2.81% | 504.44M | 4.6 | -45.77% |
| OCS | Oculis Holding AG | 7.99 | 1.98% | 484.69M | — | -60.79% |
| MNPR | Monopar Therapeutics Inc. | 71.30 | -0.75% | 480.05M | — | 10.02% |
| PHAT | Phathom Pharmaceuticals, Inc. | 6.18 | 3.26% | 474.89M | — | -63.89% |
| ARVN | Arvinas, Inc. | 7.54 | 1.21% | 474.55M | 46.0 | -37.18% |
| CBIO | Crescent Biopharma, Inc. | 13.56 | 2.18% | 473.59M | — | 11.89% |
| PRTA | Prothena Corporation plc | 9.08 | 3.05% | 452.28M | — | -7.75% |
| RGNX | REGENXBIO Inc. | 6.79 | 2.80% | 433.05M | — | -54.17% |
| ALLO | Allogene Therapeutics, Inc. | 1.33 | 8.13% | 426.68M | — | -10.22% |
| AGMB | AgomAb Therapeutics N.V. American Depositary Shares | 8.09 | -3.75% | 416.12M | — | -42.86% |
| NGNE | Neurogene Inc. | 28.90 | 7.07% | 415.66M | — | 31.02% |
| AUTL | Autolus Therapeutics plc | 1.63 | 4.84% | 415.20M | — | -22.11% |
| ASMB | Assembly Biosciences, Inc. | 20.52 | 1.06% | 409.04M | 36.5 | -40.31% |
| RZLT | Rezolute, Inc. | 4.22 | 2.56% | 394.63M | — | 74.15% |
| TECX | Tectonic Therapeutic, Inc. | 20.61 | 1.33% | 392.36M | — | -2.49% |
| SPRY | ARS Pharmaceuticals, Inc. | 3.55 | -4.82% | 361.49M | — | -67.98% |
| AAPG | Ascentage Pharma Group International | 15.10 | 1.65% | 355.12M | — | -43.41% |
| CAPR | Capricor Therapeutics, Inc. | 6.32 | 3.65% | 348.92M | — | -78.86% |
| KYTX | Kyverna Therapeutics, Inc. | 5.89 | 4.62% | 344.47M | — | -40.11% |
| RLMD | Relmada Therapeutics, Inc. | 3.27 | 1.71% | 342.41M | — | -33.54% |
| AVIR | Atea Pharmaceuticals, Inc. | 4.22 | 1.20% | 334.05M | — | 16.81% |
| XFOR | X4 Pharmaceuticals, Inc. | 3.27 | 0.46% | 314.30M | — | -18.75% |
| CTNM | Contineum Therapeutics, Inc. | 9.16 | 1.95% | 292.01M | — | -21.35% |
| IRD | Opus Genetics, Inc. | 3.58 | 3.32% | 284.95M | — | 72.14% |
| OCGN | Ocugen, Inc. | 0.77 | 1.27% | 267.73M | — | -43.90% |
| ABEO | Abeona Therapeutics Inc. | 4.55 | 2.25% | 254.47M | — | -15.56% |
| GLSI | Greenwich LifeSciences, Inc. | 17.81 | 2.24% | 249.75M | — | -17.09% |
| CABA | Cabaletta Bio, Inc. | 1.49 | 2.06% | 244.99M | — | -33.33% |
| DBVT | DBV Technologies S.A. | 10.59 | 4.59% | 242.33M | — | -47.16% |
| VNDA | Vanda Pharmaceuticals Inc. | 4.01 | 0.63% | 240.04M | — | -54.76% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | 2.96 | 3.14% | 229.85M | — | -71.10% |
| KROS | Keros Therapeutics, Inc. | 11.42 | -0.04% | 223.45M | 7.3 | -43.86% |
| PROK | ProKidney Corp. | 1.56 | 3.30% | 219.29M | — | -32.14% |
| BBOT | BridgeBio Oncology Therapeutics Inc. | 2.71 | 0.74% | 214.11M | — | -78.51% |
| BIOA | BioAge Labs Inc. | 5.78 | 5.67% | 202.37M | — | -58.65% |
| SION | Sionna Therapeutics, Inc. | 4.06 | 4.91% | 171.57M | — | -90.59% |
| VRXA | Veraxa Biotech Holding AG | 1.02 | 2.02% | 144.22M | — | -92.86% |
| EYPT | EyePoint Pharmaceuticals, Inc. | 0.39 | 7.85% | 30.18M | — | -98.01% |